Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPα interaction
- 12 April 2007
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 26 (9), 2361-2370
- https://doi.org/10.1038/sj.emboj.7601675
Abstract
Interactions between the cell cycle machinery and transcription factors play a central role in coordinating terminal differentiation and proliferation arrest. We here show that cyclin‐dependent kinase 6 (Cdk6) is specifically expressed in proliferating hematopoietic progenitor cells, and that Cdk6 inhibits transcriptional activation by Runx1, but not C/EBPα or PU.1. Cdk6 inhibits Runx1 activity by binding to the runt domain of Runx1, interfering with Runx1 DNA binding and Runx1‐C/EBPα interaction. Cdk6 expression increased myeloid progenitor proliferation, and inhibited myeloid lineage‐specific gene expression and terminal differentiation in vitro and in vivo . These effects of Cdk6 did not require Cdk6 kinase activity. Cdk6‐mediated inhibition of granulocytic differentiation could be reversed by excess Runx1, consistent with Runx1 being the major target for Cdk6. We propose that Cdk6 downregulation in myeloid progenitors releases Runx1 from Cdk6 inhibition, thereby allowing terminal differentiation. Since Runx transcription factors play central roles in hematopoietic, neuronal and osteogenic lineages, this novel, noncanonical Cdk6 function may control terminal differentiation in multiple tissues and cell types.Keywords
This publication has 31 references indexed in Scilit:
- Bone Morphogenetic Protein 2-Induced Osteoblast Differentiation Requires Smad-Mediated Down-Regulation of Cdk6Molecular and Cellular Biology, 2004
- GATA-1-Mediated Proliferation Arrest during Erythroid MaturationMolecular and Cellular Biology, 2003
- Disruption of differentiation in human cancer: AML shows the wayNature Reviews Cancer, 2003
- The core-binding factor β subunit is required for bone formation and hematopoietic maturationNature Genetics, 2002
- Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndromeNature Genetics, 2002
- CCAAT/Enhancer-binding Proteins (C/EBP) β and δ Activate Osteocalcin Gene Transcription and Synergize with Runx2 at the C/EBP Element to Regulate Bone-specific ExpressionPublished by Elsevier ,2002
- Upregulation of Flt3 Expression within the Bone Marrow Lin−Sca1+c-kit+ Stem Cell Compartment Is Accompanied by Loss of Self-Renewal CapacityImmunity, 2001
- Self-Renewal of Multipotent Long-Term Repopulating Hematopoietic Stem Cells Is Negatively Regulated by FAS and Tumor Necrosis Factor Receptor ActivationThe Journal of Experimental Medicine, 2001
- C/EBPα Inhibits Cell Growth via Direct Repression of E2F-DP-Mediated TranscriptionMolecular and Cellular Biology, 2000
- Reciprocal Regulation of Adipogenesis by Myc and C/EBPαScience, 1992